???global.info.a_carregar???
Luís Jorge Lopes Botelho Antunes. Concluiu o(a) Doutoramento em Matemática Aplicada em 2018/12/13 pelo(a) Universidade do Porto Faculdade de Ciências, Mestrado em MESTRADO EM MATEMÁTICA em 2009 pelo(a) Universidade do Porto Faculdade de Ciências e Licenciatura em LICENCIATURA EM ENGENHARIA QUÍMICA em 1995 pelo(a) Universidade do Porto Faculdade de Engenharia. É Professor Adjunto Convidado no(a) Instituto Politécnico do Porto Escola Superior de Saúde e Consultor sénior bioestatística - Ciência de dados de saúde no(a) IQVIA Portugal. Publicou 108 artigos em revistas especializadas. Participa e/ou participou como Investigador em 2 projeto(s). Atua na(s) área(s) de Ciências Exatas com ênfase em Matemática com ênfase em Estatística e Probabilidades e Ciências Médicas e da Saúde com ênfase em Ciências da Saúde com ênfase em Epidemiologia. Nas suas atividades profissionais interagiu com 514 colaborador(es) em coautorias de trabalhos científicos. No seu currículo Ciência Vitae os termos mais frequentes na contextualização da produção científica, tecnológica e artístico-cultural são: Análise de Sobrevivência; Prehabilitação; Cancro; Resposta tumoral à terapia; Complicações pós-cirúrgicas ; Bio-medicina de Sistemas; gestão de dados; cancro; prever o risco; Genética do cancro; Epigenética do cancro; Oncologia molecular; Terapia experimental e radiobiologia; Epidemiologia; Saúde Pública; Investigação de resultados; Ciclo de vida; .
Identificação

Identificação pessoal

Nome completo
Luís Jorge Lopes Botelho Antunes

Nomes de citação

  • Antunes, Luís

Identificadores de autor

Ciência ID
191A-2C57-EDA4
ORCID iD
0000-0002-3098-0711

Domínios de atuação

  • Ciências Exatas - Matemática - Estatística e Probabilidades
  • Ciências Médicas e da Saúde - Ciências da Saúde - Epidemiologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador independente (B1)
Francês Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2018/12/13
Concluído
Matemática Aplicada (Doutoramento)
Especialização em Sem especialidade
Universidade do Porto Faculdade de Ciências, Portugal
"Statistical models in cancer survival - Application to study of prognostic factors in the presence of incomplete data" (TESE/DISSERTAÇÃO)
2009
Concluído
MESTRADO EM MATEMÁTICA (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
"MODELAÇÃO DE EXTREMOS USANDO COVARIÁVEIS" (TESE/DISSERTAÇÃO)
18
2003 - 2004
Concluído
Mestrado em Ecologia, Gestão e Modelação dos Recursos Marinhos, ramo Modelação do Ambiente (Curso de mestrado (conclusão do curso de especialização))
Especialização em Modelação do Ambiente
Universidade de Lisboa Instituto Superior Técnico, Portugal
1998
Concluído
Engenharia do Ambiente – Ramo Tratamento de Águas e Águas Residuais (Pós-Graduação)
Universidade do Porto Faculdade de Engenharia, Portugal
"n/a" (TESE/DISSERTAÇÃO)
15
1995
Concluído
LICENCIATURA EM ENGENHARIA QUÍMICA (Licenciatura)
Universidade do Porto Faculdade de Engenharia, Portugal
"n/a" (TESE/DISSERTAÇÃO)
14
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
Empregador
2019/09 - Atual Professor Adjunto Convidado (Docente Ensino Superior Politécnico) Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2019/09 - 2020/08 Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013/09 - 2020/08 Assistente Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2011/10 - 2019/10 Assistente convidado (Docente Ensino Superior Politécnico) Instituto Politécnico do Porto, Portugal
2011/09/01 - 2019/09/14 Assistente convidado (Docente Ensino Superior Politécnico) Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2014 - 2019 Assistente Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2001 - 2012 Assistente convidado (Docente Ensino Superior Politécnico) Instituto Superior de Tecnologias Avançadas de Lisboa Porto, Portugal

Outras Carreiras

Categoria Profissional
Instituição de acolhimento
Empregador
2009/06/15 - 2020/09 Técnico Superior (Técnico Superior) Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2020/09 - Atual Consultor sénior bioestatística - Ciência de dados de saúde IQVIA Portugal, Portugal
IQVIA Portugal, Portugal
Projetos

Projeto

Designação Financiadores
2021/01/01 - 2023/12/31 Pré-habilitação para melhorar o tratamento oncológico em doentes com adenocarcinoma da junção gastroesofágica e do estômago
PTDC/SAU-DES/7945/2020
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade do Porto Faculdade de Desporto, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Fundação para a Ciência e a Tecnologia
Em curso
2019/01/17 - 2022/07/16 Prever o risco de complicações do tratamento cirúrgico e definir o prognóstico em pacientes com cancro através da integração de dados clínicos e patológicos.
DSAIPA/DS/0042/2018
Investigador
Instituto de Engenharia Mecânica, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2019/01/01 - 2019/12/31 Centro de Investigação do Instituto Português de Oncologia do Porto
UID/DTP/00776/2019
UID/DTP/04750/2019
UIDB/04750/2020
UIDB/00776/2020
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal

Universidade do Porto Instituto de Saúde Pública, Portugal

Universidade do Porto Faculdade de Medicina, Portugal

Universidade do Porto Unidade de Investigação em Epidemiologia, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
Produções

Publicações

Artigo em revista
  1. Benoist C; Boccaletti S; Leach JP; Cattaneo A; Chaplin A; Antunes L; Heiman F; Sander JW. "Characterising people with focal drug-resistant epilepsy: A retrospective cohort study.". Epilepsy & behavior : E&B (2023): http://europepmc.org/abstract/med/38006844.
    10.1016/j.yebeh.2023.109540
  2. Barbosa B; Oliveira C; Bravo I; Couto JG; Antunes L; McFadden S; Hughes C; et al. "An investigation of digital skills of therapeutic radiographers/radiation therapists: A european survey of proficiency level and future educational needs.". Radiography (London, England : 1995) (2023): http://europepmc.org/abstract/med/36878157.
    10.1016/j.radi.2023.02.009
  3. Jane Friestino; Denisa Mendonça; Pedro Oliveira; Luis Antunes; Rosemeire Olanda Ferraz; Priscila Francisco; Djalma Carvalho Moreira Filho. "Sobrevivência do câncer entre crianças e adolescentes em um serviço brasileiro de referência". Estrabão (2023): https://doi.org/10.53455/re.v4i.2.
    10.53455/re.v4i.2
  4. Vieira C; Borges A; Pereira FF; Antunes P; Redondo P; Antunes L; Lopes JM; et al. "Pertuzumab in Combination with Trastuzumab and Docetaxel in the Neoadjuvant Treatment for HER2-Positive Breast Cancer.". Journal of immunotherapy and precision oncology (2022): http://europepmc.org/abstract/med/36751658.
    10.36401/jipo-22-12
  5. B. Barbosa; I. Bravo; C. Oliveira; L. Antunes; J.G. Couto; S. McFadden; C. Hughes; P. McClure; A.G. Dias. "Digital skills of therapeutic radiographers/radiation therapists – Document analysis for a European educational curriculum". Radiography (2022): https://doi.org/10.1016/j.radi.2022.06.017.
    10.1016/j.radi.2022.06.017
  6. Ana Ribeiro; Jéssica Rodrigues; Luís Antunes; Sandra Sarmento. "Radiation doses in mammography exams: Effects of oncological treatments". Radiation Physics and Chemistry 198 (2022): 110286-110286. https://doi.org/10.1016/j.radphyschem.2022.110286.
    10.1016/j.radphyschem.2022.110286
  7. Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N. "The impact of the coronavirus disease 2019 pandemic on the diagnosis and treatment of cancer in Northern Portugal.". European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (2022): http://europepmc.org/abstract/med/34267109.
    10.1097/cej.0000000000000686
  8. Luís Antunes; Denisa Mendonça; Maria José Bento; Edmund Njeru Njagi; Aurélien Belot; Bernard Rachet. "Dealing with missing information on covariates for excess mortality hazard regression models – Making the imputation model compatible with the substantive model". Statistical Methods in Medical Research 30 10 (2021): 2256-2268. https://doi.org/10.1177/09622802211031615.
    10.1177/09622802211031615
  9. Guerreiro T; Forjaz G; Antunes L; Bastos J; Mayer A; Aguiar P; Araújo A; Nunes C. "Lung cancer survival and sex-specific patterns in Portugal: A population-based analysis.". Pulmonology (2021): http://europepmc.org/abstract/med/34642125.
    10.1016/j.pulmoe.2021.09.001
  10. Borges A; Pereira F; Redondo P; Antunes L; Vieira C; Antunes P; Bento MJ; et al. "The addition of neoadjuvant pertuzumab for the treatment of HER2+ breast cancer: a cost estimate with real-world data.". Health economics review (2021): http://europepmc.org/abstract/med/34505956.
    10.1186/s13561-021-00332-0
  11. Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N. "The impact of the COVID-19 pandemic on cancer screening.". European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (2021): http://europepmc.org/abstract/med/34456263.
    10.1097/cej.0000000000000720
  12. Soares M; Antunes L; Redondo P; Borges M; Grimson F; Hermans R; Chaib C; et al. "Small cell lung cancer treatment and survival in Portugal: A retrospective analysis from the I-O Optimise initiative.". European journal of cancer care (2021): http://europepmc.org/abstract/med/34288191.
    10.1111/ecc.13496
  13. Marta Soares; Luís Antunes; Patrícia Redondo; Marina Borges; Ruben Hermans; Dony Patel; Fiona Grimson; et al. "Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital database". Lung Cancer Management 10 2 (2021): LMT46-LMT46. https://doi.org/10.2217/lmt-2020-0028.
    10.2217/lmt-2020-0028
  14. Morais S; Antunes L; Rodrigues J; Fontes F; Bento MJ; Lunet N. "The impact of the COVID-19 pandemic on the short-term survival of patients with cancer in Northern Portugal.". International journal of cancer (2021): http://europepmc.org/abstract/med/33634852.
    10.1002/ijc.33532
  15. Morais, Samantha; Antunes, Luís; Rocha-Rodrigues, Jessica; Fontes, Filipa; Bento, Maria José; Lunet, Nuno. "The impact of the COVID-19 pandemic on the diagnosis and treatment of cancer in Northern Portugal". European Journal of Cancer Prevention (2021):
    Aceite para publicação
  16. Rita Silva-Oliveira; Filipa Ferreira Pereira; Sara Petronilho; Ana Teresa Martins; Ana Lameirinhas; Vera Constâncio; Inês Caldas-Ribeiro; et al. "Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer". Journal of Clinical Medicine 9 12 (2020): 3911-3911. https://doi.org/10.3390/jcm9123911.
    10.3390/jcm9123911
  17. Marta Soares; Luís Antunes; Patrícia Redondo; Marina Borges; Ruben Hermans; Dony Patel; Fiona Grimson; et al. "Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative". BMC Pulmonary Medicine 20 1 (2020): https://doi.org/10.1186/s12890-020-01270-z.
    10.1186/s12890-020-01270-z
  18. Sérgio Machado Lopes; Susana Roncon; Ana Catarina Pinho; Filipa Bordalo; Luís Antunes; Fernando Campilho; António Campos; Altamiro Costa-Pereira. "Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker". Future Science OA 6 8 (2020): FSO623-FSO623. https://doi.org/10.2144/fsoa-2020-0107.
    10.2144/fsoa-2020-0107
  19. Lobo J; Guimarães R; Miranda-Gonçalves V; Monteiro-Reis S; Cantante M; Antunes L; Braga I; et al. "Differential expression of DNA methyltransferases and demethylases among the various testicular germ cell tumor subtypes.". Epigenomics (2020): http://europepmc.org/abstract/med/32957806.
    10.2217/epi-2020-0066
  20. Guerreiro T; Antunes L; Bastos J; Mayer A; Forjaz G; Araujo A; Nunes C. "Lung Cancer: A Nationwide Study to Characterize Sex Differences, Incidence, and Spatial Patterns in Portugal.". In vivo (Athens, Greece) (2020): http://europepmc.org/abstract/med/32871804.
    10.21873/invivo.12092
  21. Fernandes A; Rodrigues J; Antunes L; Lages P; Santos CS; Moreira-Gonçalves D; Costa RS; et al. "Development of a preoperative risk score on admission in surgical intermediate care unit in gastrointestinal cancer surgery.". Perioperative medicine (London, England) (2020): http://europepmc.org/abstract/med/32774846.
    10.1186/s13741-020-00151-7
  22. Morais A; Simão M; Cossa M; Come J; Selemane C; Tivane A; Tulsidás S; et al. "Designing a National Curriculum to Advance Surgical Oncology in Mozambique: A Delphi Consensus Study.". Journal of surgical education (2020): http://europepmc.org/abstract/med/32646814.
    10.1016/j.jsurg.2020.06.030
  23. Sousa Menezes A; Fernandes A; Rocha Rodrigues J; Salomé C; Machado F; Antunes L; Castro Silva J; Monteiro E; Lara Santos L. "Optimizing classical risk scores to predict complications in head and neck surgery: a new approach.". European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2020): http://europepmc.org/abstract/med/32556466.
    10.1007/s00405-020-06133-1
  24. Inês Maria Guerreiro; Daniela Barros-Silva; Paula Lopes; Mariana Cantante; Ana Luísa Cunha; João Lobo; Luís Antunes; et al. "RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer". Journal of Clinical Medicine 9 4 (2020): 1000-1000. https://doi.org/10.3390/jcm9041000.
    10.3390/jcm9041000
  25. Sara Monteiro-Reis; Ana Blanca; Joana Tedim-Moreira; Isa Carneiro; Diana Montezuma; Paula Monteiro; Jorge Oliveira; et al. "A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions". Journal of Clinical Medicine 9 2 (2020): 605-605. https://doi.org/10.3390/jcm9020605.
    10.3390/jcm9020605
  26. Fontes-Sousa M; Lobo J; Lobo S; Salta S; Amorim M; Lopes P; Antunes L; et al. "Digital imaging-assisted quantification of H3K27me3 immunoexpression in luminal A/B-like, HER2-negative, invasive breast cancer predicts patient survival and risk of recurrence.". Molecular medicine (Cambridge, Mass.) (2020): http://europepmc.org/abstract/med/32050892.
    10.1186/s10020-020-0147-5
  27. Karalexi MA; Dessypris N; Georgakis MK; Ryzhov A; Jakab Z; Zborovskaya A; Dimitrova N; et al. "Birth seasonality of childhood central nervous system tumors: Analysis of primary data from 16 Southern-Eastern European population-based registries.". International journal of cancer (2020): http://europepmc.org/abstract/med/31957026.
    10.1002/ijc.32875
  28. Sampaio IL; Luíz HV; Violante LS; Santos AP; Antunes L; Torres I; Sanches C; Azevedo I; Duarte H. "[Errata to the article "Treatment of Gastroenteropancreatic Neuroendocrine Tumors with 177Lu-DOTA-TATE: Experience of the Portuguese Institute of Oncology in Porto" by Inês Lucena Sampaio, Henrique Vara Luiz, Liliana Sobral Violante, Ana Paula Santos, Luís Antunes, Isabel Torres, Cristina Sanches, Isabel Azevedo, Hugo Duarte published on Acta Med Port 2016 Nov;29(11):726-733].". Acta medica portuguesa (2020): http://europepmc.org/abstract/med/31928610.
    10.20344/amp.12994
  29. Luís Antunes; Denisa Mendonça; Ana Isabel Ribeiro; Camille Maringe; Bernard Rachet. "Deprivation-specific life tables using multivariable flexible modelling – trends from 2000–2002 to 2010–2012, Portugal". BMC Public Health (2019): https://doi.org/10.1186/s12889-019-6579-6.
    10.1186/s12889-019-6579-6
  30. Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; et al. "Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.". Journal of translational medicine (2019): http://europepmc.org/abstract/med/31888645.
    10.1186/s12967-019-02193-y
  31. Fernandes A; Rodrigues J; Lages P; Lança S; Mendes P; Antunes L; Santos CS; et al. "Root causes and outcomes of postoperative pulmonary complications after abdominal surgery: a retrospective observational cohort study.". Patient safety in surgery (2019): http://europepmc.org/abstract/med/31827617.
    10.1186/s13037-019-0221-5
  32. Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Soares M; et al. "Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.". Clinical epigenetics (2019): http://europepmc.org/abstract/med/31791387.
    10.1186/s13148-019-0779-x
  33. Bielska-Lasota M; Rossi S; Krzyzak M; Haelens A; Domenic A; De Angelis R; Maciejczyk A; et al. "Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study.". Archives of gynecology and obstetrics (2019): http://europepmc.org/abstract/med/31853712.
    10.1007/s00404-019-05412-5
  34. João Lobo; Sara Petronilho; Amy Hanlon Newell; Julia Coach; Greg Harlow; Andréia Cruz; Paula Lopes; et al. "E-cadherin clone 36 nuclear staining dictates adverse disease outcome in lobular breast cancer patients". Modern Pathology 32 11 (2019): 1574-1586. https://doi.org/10.1038/s41379-019-0294-9.
    10.1038/s41379-019-0294-9
  35. Antunes L; Bento MJ; Sobrinho-Simões M; Soares P; Boaventura P. "Cancer incidence after childhood irradiation for tinea capitis in a portuguese cohort.". The British journal of radiology (2019): http://europepmc.org/abstract/med/31674803.
    10.1259/bjr.20180677
  36. Morais S; Antunes L; Bento MJ; Lunet N. "The effect of a gastric second primary cancer on the survival of patients with a previous cancer history.". European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (2019): http://europepmc.org/abstract/med/31651567.
    10.1097/cej.0000000000000540
  37. Ana P Santos; Clara Castro; Luis Antunes; Rui Henrique; M. Helena Cardoso; Monteiro MP. "Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome". Journal of Clinical Medicine (2019): https://www.mdpi.com/2077-0383/8/9/1479.
    10.3390/jcm8091479
  38. Amorim M; Lobo J; Fontes-Sousa M; Estevão-Pereira H; Salta S; Lopes P; Coimbra N; et al. "Predictive and Prognostic Value of Selected MicroRNAs in Luminal Breast Cancer.". Frontiers in genetics (2019): http://europepmc.org/abstract/med/31572437.
    10.3389/fgene.2019.00815
  39. Nunes SP; Diniz F; Moreira-Barbosa C; Constâncio V; Silva AV; Oliveira J; Soares M; et al. "Subtyping Lung Cancer Using DNA Methylation in Liquid Biopsies.". Journal of clinical medicine (2019): http://europepmc.org/abstract/med/31546933.
    10.3390/jcm8091500
  40. Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; et al. "Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.". Frontiers in oncology (2019): http://europepmc.org/abstract/med/31572685.
    10.3389/fonc.2019.00900
  41. Vieira-Silva TS; Monteiro-Reis S; Barros-Silva D; Ramalho-Carvalho J; Graça I; Carneiro I; Martins AT; et al. "Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype.". Cancer Cell International (2019): http://europepmc.org/abstract/med/31164793.
    10.1186/s12935-019-0835-9
  42. Luís Antunes; Francisco Rocha-Gonçalves; Sérgio Chacim; Cinira Lefèvre; Marta Pereira; Sónia Pereira; Aleksandra Zagorska; Maria José Bento. "Real-world treatment patterns, resource use and cost burden of multiple myeloma in Portugal". European Journal of Cancer Care (2019): e13026-e13026. https://doi.org/10.1111/ecc.13026.
    10.1111/ecc.13026
  43. Lobo J; Costa AL; Cantante M; Guimarães R; Lopes P; Antunes L; Braga I; et al. "m6A RNA modification and its writer/reader VIRMA/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance.". Journal of translational medicine (2019): http://europepmc.org/abstract/med/30866959.
    10.1186/s12967-019-1837-z
  44. Morais S; Antunes L; Bento MJ; Lunet N. "The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer.". European journal of gastroenterology & hepatology (2019): http://europepmc.org/abstract/med/30601339.
    10.1097/meg.0000000000001348
  45. Sandra Saleiro; Luís Rocha; João Bento; Luís Antunes; José Torres da Costa. "Occupational exposure to dust: an underestimated health risk?". Jornal Brasileiro de Pneumologia 45 4 (2019): https://doi.org/10.1590/1806-3713/e20170396.
    10.1590/1806-3713/e20170396
  46. Morais, Atílio; Come, Jotamo; Selemane, Carlos; Pires, Germano; Tivane, Adriano; Cossa, Matchecane; Tulsidás, Satish; et al. "Understanding the bricks to build better surgical oncology unit at Maputo Central Hospital: prevalent surgical cancers and residents knowledge". Pan African Medical Journal 32 (2019): http://dx.doi.org/10.11604/pamj.2019.32.83.18126.
    10.11604/pamj.2019.32.83.18126
  47. Morais S; Antunes L; Bento MJ; Lunet N. "Risk and survival of third primary cancers in a population-based cohort of gastric cancer patients.". Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (2018): http://europepmc.org/abstract/med/30591366.
    10.1016/j.dld.2018.12.003
  48. Morais S; Antunes L; Bento MJ; Lunet N. "Second primary gastric cancers in a region with an overall high risk of gastric cancer.". Gaceta sanitaria (2018): http://europepmc.org/abstract/med/30527910.
    10.1016/j.gaceta.2018.08.010
  49. Costa AL; Moreira-Barbosa C; Lobo J; Vilela-Salgueiro B; Cantante M; Guimarães R; Lopes P; et al. "DNA methylation profiling as a tool for testicular germ cell tumors subtyping.". Epigenomics (2018): http://europepmc.org/abstract/med/30418048.
    10.2217/epi-2018-0034
  50. Salta S; P Nunes S; Fontes-Sousa M; Lopes P; Freitas M; Caldas M; Antunes L; et al. "A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.". Journal of clinical medicine (2018): http://europepmc.org/abstract/med/30405052.
    10.3390/jcm7110420
  51. Moreira-Barbosa C; Barros-Silva D; Costa-Pinheiro P; Torres-Ferreira J; Constâncio V; Freitas R; Oliveira J; et al. "Comparing diagnostic and prognostic performance of two-gene promoter methylation panels in tissue biopsies and urines of prostate cancer patients.". Clinical epigenetics (2018): http://europepmc.org/abstract/med/30373654.
    10.1186/s13148-018-0564-2
  52. Nunes SP; Moreira-Barbosa C; Salta S; Palma de Sousa S; Pousa I; Oliveira J; Soares M; et al. "Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women.". Cancers (2018): http://europepmc.org/abstract/med/30261643.
    10.3390/cancers10100357
  53. Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; et al. "Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.". Journal of cancer research and clinical oncology (2018): http://europepmc.org/abstract/med/30105513.
    10.1007/s00432-018-2733-2
  54. Ferreira C; Lobo J; Antunes L; Lopes P; Jerónimo C; Henrique R. "Differential expression of E-cadherin and P-cadherin in pT3 prostate cancer: correlation with clinical and pathological features.". Virchows Archiv : an international journal of pathology (2018): http://europepmc.org/abstract/med/30006753.
    10.1007/s00428-018-2406-1
  55. Doganis D; Panagopoulou P; Tragiannidis A; Vichos T; Moschovi M; Polychronopoulou S; Rigatou E; et al. "Survival and mortality rates of Wilms tumour in Southern and Eastern European countries: Socioeconomic differentials compared with the United States of America.". European journal of cancer (Oxford, England : 1990) (2018): http://europepmc.org/abstract/med/30014973.
    10.1016/j.ejca.2018.06.012
  56. Lobo J; Costa AL; Vilela-Salgueiro B; Rodrigues Â; Guimarães R; Cantante M; Lopes P; et al. "Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists.". Human pathology (2018): http://europepmc.org/abstract/med/30041024.
    10.1016/j.humpath.2018.07.016
  57. Monteiro LS; Antunes L; Santos LL; Bento MJ; Warnakulasuriya S. "Survival probabilities and trends for lip, oral cavity and oropharynx cancers in Northern Portugal in the period 2000-2009.". Ecancermedicalscience (2018): http://europepmc.org/abstract/med/30093917.
    10.3332/ecancer.2018.855
  58. Panagopoulou P; Georgakis MK; Baka M; Moschovi M; Papadakis V; Polychronopoulou S; Kourti M; et al. "Persisting inequalities in survival patterns of childhood neuroblastoma in Southern and Eastern Europe and the effect of socio-economic development compared with those of the US.". European journal of cancer (Oxford, England : 1990) (2018): http://europepmc.org/abstract/med/29673989.
    10.1016/j.ejca.2018.03.003
  59. Morais S; Castro C; Antunes L; Peleteiro B; Bento MJ; Lunet N. "Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles.". European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (2018): http://europepmc.org/abstract/med/29668653.
    10.1097/cej.0000000000000447
  60. Doganis D; Panagopoulou P; Tragiannidis A; Georgakis MK; Moschovi M; Polychronopoulou S; Rigatou E; et al. "Childhood nephroblastoma in Southern and Eastern Europe and the US: Incidence variations and temporal trends by human development index.". Cancer epidemiology (2018): http://europepmc.org/abstract/med/29655086.
    10.1016/j.canep.2018.03.012
  61. Allemani C; Matsuda T; Di Carlo V; Harewood R; Matz M; Nikšic M; Bonaventure A; et al. "Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37¿513¿025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.". Lancet (London, England) (2018): http://europepmc.org/abstract/med/29395269.
    10.1016/s0140-6736(17)33326-3
  62. Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; et al. "A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.". Journal of translational medicine (2018): http://europepmc.org/abstract/med/29486770.
    10.1186/s12967-018-1415-9
  63. Antunes, Luís. "Neuroblastoma among children in Southern and Eastern European cancer registries: Variations in incidence and temporal trends compared to US.". International journal of cancer (2017): http://europepmc.org/abstract/med/29250786.
    10.1002/ijc.31222
  64. Antunes, Luís. "Western long-term accuracy of serum pepsinogen-based gastric cancer screening.". European journal of gastroenterology & hepatology (2017): http://europepmc.org/abstract/med/29215432.
    10.1097/meg.0000000000001040
  65. Antunes, Luís. "Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404].". Gynecologic oncology (2017): http://europepmc.org/abstract/med/28688523.
    10.1016/j.ygyno.2017.06.033
  66. Antunes, Luís. "Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413].". Gynecologic oncology (2017): http://europepmc.org/abstract/med/28687170.
    10.1016/j.ygyno.2017.06.032
  67. Antunes, Luís. "High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.". Urologic oncology (2017): http://europepmc.org/abstract/med/29174711.
    10.1016/j.urolonc.2017.10.028
  68. Antunes, Luís. "Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.". Cancer (2017): http://europepmc.org/abstract/med/28708937.
    10.1002/cncr.30884
  69. Antunes, Luís. "SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.". Epigenetics (2017): http://europepmc.org/abstract/med/29099276.
    10.1080/15592294.2017.1385685
  70. Antunes, Luís. "Central nervous system tumours among adolescents and young adults (15-39 years) in Southern and Eastern Europe: Registration improvements reveal higher incidence rates compared to the US.". European journal of cancer (Oxford, England : 1990) (2017): http://europepmc.org/abstract/med/28961466.
    10.1016/j.ejca.2017.08.030
  71. Antunes, Luís. "Risk of second primary cancers among patients with a first primary gastric cancer: A population-based study in North Portugal.". Cancer epidemiology (2017): http://europepmc.org/abstract/med/28843176.
    10.1016/j.canep.2017.08.007
  72. Antunes, Luís. "Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study.". European journal of cancer (Oxford, England : 1990) (2017): http://europepmc.org/abstract/med/28865261.
    10.1016/j.ejca.2017.07.015
  73. Antunes, Luís. "Cumulative incidence estimates in the presence of competing risks.". Journal of clinical epidemiology (2017): http://europepmc.org/abstract/med/28919462.
    10.1016/j.jclinepi.2017.09.011
  74. Antunes, Luís. "Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.". Journal of translational medicine (2017): http://europepmc.org/abstract/med/28662726.
    10.1186/s12967-017-1248-y
  75. Antunes L; Santos LL; Bento MJ. "Survival from cancer in the north region of Portugal: results from the first decade of the millennium.". (2017): http://europepmc.org/abstract/med/28590274.
    10.1097/cej.0000000000000378
  76. Bonaventure A; Harewood R; Stiller CA; Gatta G; Clavel J; Stefan DC; Carreira H; et al. "Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89¿828 children from 198 registries in 53 countries.". (2017): http://europepmc.org/abstract/med/28411119.
    10.1016/s2352-3026(17)30052-2
  77. Padrão NA; Monteiro-Reis S; Torres-Ferreira J; Antunes L; Leça L; Montezuma D; Ramalho-Carvalho J; et al. "MicroRNA promoter methylation: a new tool for accurate detection of urothelial carcinoma.". (2017): http://europepmc.org/abstract/med/28081549.
    10.1038/bjc.2016.454
  78. Torres-Ferreira J; Ramalho-Carvalho J; Gomez A; Menezes FD; Freitas R; Oliveira J; Antunes L; et al. "MiR-193b promoter methylation accurately detects prostate cancer in urine sediments and miR-34b/c or miR-129-2 promoter methylation define subsets of clinically aggressive tumors.". (2017): http://europepmc.org/abstract/med/28143614.
  79. Bordoni A; Uhry Z; Antunes L; GRELL EUROCARE-5 Working Group. "Trends in net survival lung cancer in six European Latin countries: results from the SUDCAN population-based study.". (2017): http://europepmc.org/abstract/med/28005608.
    10.1097/cej.0000000000000299
  80. Antunes L; Roche L; José Bento M; GRELL EUROCARE-5 Working Group. "Trends in net survival from corpus uteri cancer in six European Latin countries: results from the SUDCAN population-based study.". (2017): http://europepmc.org/abstract/med/28005612.
    10.1097/cej.0000000000000294
  81. Karalexi MA; Baka M; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; Eser S; et al. "Survival trends in childhood chronic myeloid leukaemia in Southern-Eastern Europe and the United States of America.". (2016): http://europepmc.org/abstract/med/27677054.
    10.1016/j.ejca.2016.08.011
  82. Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; et al. "Epigenetic Disruption of miR-130a Promotes Prostate Cancer By Targeting SEC23B and DEPDC1.". (2016): http://europepmc.org/abstract/med/27984115.
    10.1016/j.canlet.2016.10.028
  83. Georgakis MK; Karalexi MA; Agius D; Antunes L; Bastos J; Coza D; Demetriou A; et al. "Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA.". (2016): http://europepmc.org/abstract/med/27757777.
  84. Georgakis MK; Karalexi MA; Kalogirou EI; Ryzhov A; Zborovskaya A; Dimitrova N; Eser S; et al. "Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US.". (2016): http://europepmc.org/abstract/med/27743145.
  85. Santos TS; Estêvão R; Antunes L; Certal V; Silva JC; Monteiro E. "Clinical and histopathological prognostic factors in locoregional advanced laryngeal cancer.". (2016): http://europepmc.org/abstract/med/27774922.
  86. Karalexi MA; Georgakis MK; Dessypris N; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; et al. "Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.". (2016): http://europepmc.org/abstract/med/27641612.
    10.1002/hon.2347
  87. Bartosch C; Afonso M; Pires-Luís AS; Galaghar A; Guimarães M; Antunes L; Lopes JM. "Distant Metastases in Uterine Leiomyosarcomas: The Wide Variety of Body Sites and Time Intervals to Metastatic Relapse.". (2016): http://europepmc.org/abstract/med/27015437.
  88. Freitas R; Cruz R; Antunes L; Araújo P; Silva P; Saraiva L; Magalhães S; et al. "Parcial Nephrectomies - results of 12 years from an Oncology Institution.". (2016): http://europepmc.org/abstract/med/27234952.
    10.20344/amp.5231
  89. Pires-Luís AS; Vieira-Coimbra M; Ferreira MJ; Ramalho-Carvalho J; Costa-Pinheiro P; Antunes L; Dias PC; et al. "Prognostic significance of MST1R dysregulation in renal cell tumors.". (2016): http://europepmc.org/abstract/med/27648366.
  90. Antunes L; Mendonça D; Bento MJ; Rachet B. "No inequalities in survival from colorectal cancer by education and socioeconomic deprivation - a population-based study in the North Region of Portugal, 2000-2002.". (2016): http://europepmc.org/abstract/med/27495309.
    10.1186/s12885-016-2639-9
  91. Pires-Luís AS; Vieira-Coimbra M; Vieira FQ; Costa-Pinheiro P; Silva-Santos R; Dias PC; Antunes L; et al. "Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.". (2015): http://europepmc.org/abstract/med/26488939.
  92. Karalexi MA; Papathoma P; Thomopoulos TP; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; et al. "Childhood central nervous system tumour mortality and survival in Southern and Eastern Europe (1983-2014): Gaps persist across 14 cancer registries.". (2015): http://europepmc.org/abstract/med/26343313.
    10.1016/j.ejca.2015.08.018
  93. Castro C; Antunes L; Lunet N; Bento MJ. "Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date.". (2015): http://europepmc.org/abstract/med/26317384.
  94. Pacheco-Figueiredo L; Antunes L; Bento MJ; Lunet N. "Incidence of second primary cancers in North Portugal-a population-based study.". (2015): http://europepmc.org/abstract/med/26159159.
    10.1007/s11764-015-0460-0
  95. Ana Sílvia Pires-Luís; Francisco Lobo; Márcia Vieira-Coimbra; Pedro Costa-Pinheiro; Luís Antunes; Jorge Oliveira; Rui Henrique; Carmen Jerónimo. "MST1R methylation as a diagnostic biomarker in renal cell tumors". Acta Urológica Portuguesa (2015): https://doi.org/10.1016%2Fj.acup.2015.01.004.
    10.1016/j.acup.2015.01.004
  96. Papathoma P; Thomopoulos TP; Karalexi MA; Ryzhov A; Zborovskaya A; Dimitrova N; Zivkovic S; et al. "Childhood central nervous system tumours: Incidence and time trends in 13 Southern and Eastern European cancer registries.". (2015): http://europepmc.org/abstract/med/25971531.
    10.1016/j.ejca.2015.04.014
  97. Monteiro LS; Warnakulasuriya S; Cadilhe S; Sousa D; Trancoso PF; Antunes L; Salazar F; Pacheco JJ. "Oral cancer awareness and knowledge among residents in the Oporto city, Portugal.". (2015): http://europepmc.org/abstract/med/25976280.
    10.1111/jicd.12158
  98. Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; et al. "Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).". (2015): http://europepmc.org/abstract/med/25467588.
    10.1016/S0140-6736(14)62038-9
  99. José Bento M; Gonçalves G; Aguiar A; Antunes L; Veloso V; Rodrigues V. "Clinicopathological differences between interval and screen-detected breast cancers diagnosed within a screening programme in Northern Portugal.". (2014): http://europepmc.org/abstract/med/24803482.
    10.1177/0969141314534406
  100. De Angelis R; Sant M; Coleman MP; Francisci S; Baili P; Pierannunzio D; Trama A; et al. "Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.". (2014): http://europepmc.org/abstract/med/24314615.
    10.1016/S1470-2045(13)70546-1
  101. Monteiro-Reis, S.; Leça, L.; Almeida, M.; Antunes, L.; Monteiro, P.; Dias, P. C.; Morais, A.; et al. "Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation". Eur J Cancer 50 1 (2014): 226-33.
    10.1016/j.ejca.2013.08.025
  102. Vieira, F. Q.; Costa-Pinheiro, P.; Ramalho-Carvalho, J.; Pereira, A.; Menezes, F. D.; Antunes, L.; Carneiro, I.; et al. "Deregulated expression of selected histone methylases and demethylases in prostate carcinoma". Endocr Relat Cancer 21 1 (2014): 51-61.
    10.1530/ERC-13-0375
  103. Silva-Santos, R. M.; Costa-Pinheiro, P.; Luis, A.; Antunes, L.; Lobo, F.; Oliveira, J.; Henrique, R.; Jerónimo, C.. "MicroRNA profile: a promising ancillary tool for accurate renal cell tumour diagnosis". Br J Cancer 109 10 (2013): 2646-53.
    10.1038/bjc.2013.552
  104. Pacheco-Figueiredo, L.; Antunes, L.; Bento, M. J.; Lunet, N.. "Evaluation of the frequency of and survival from second primary cancers in North Portugal: a population-based study". Eur J Cancer Prev 22 6 (2013): 599-606.
    10.1097/CEJ.0b013e328345f923
  105. Monteiro, L. S.; Antunes, L.; Bento, M. J.; Warnakulasuriya, S.. "Incidence rates and trends of lip, oral and oro-pharyngeal cancers in Portugal". J Oral Pathol Med 42 4 (2013): 345-51.
    10.1111/jop.12010
  106. Junqueira-Neto, S.; Vieira, F. Q.; Montezuma, D.; Costa, N. R.; Antunes, L.; Baptista, T.; Oliveira, A. I.; et al. "Phenotypic impact of deregulated expression of class I histone deacetylases in urothelial cell carcinoma of the bladder". Mol Carcinog (2013):
    10.1002/mc.22117
  107. Gonçalves, F.; Almeida, A.; Antunes, L.; Teixeira, S.; Pereira, S.; Edra, N.. "Variation in the incidence of agitated delirium during the day in a palliative care unit: a preliminary report". Am J Hosp Palliat Care 30 2 (2013): 111-3.
    10.1177/1049909112444302
  108. Carreira, H.; Antunes, L.; Castro, C.; Lunet, N.; Bento, M. J.. "Cancer incidence and survival (1997-2006) among adolescents and young adults in the north of Portugal". Pediatr Hematol Oncol 29 7 (2012): 663-76.
    10.3109/08880018.2012.719069
Poster em conferência
  1. Monteiro-Reis, Sara; Blanca, Ana; Moreira, Joana; Antunes, Luís; Carneiro, Isa; Oliveira, Jorge; Monteiro, Paula; et al. Autor correspondente: Monteiro-Reis, Sara. "MiR663a and VIM promoter methylation: a multiplex test for discriminating bladder cancer from inflammatory disease". Trabalho apresentado em 26th Meeting of the EAU Section of Urological Research (ESUR), 2019.
    10.1016/S1569- 9056(19)33332-9
  2. Morais, Samantha; Fontes, Filipa; Rocha-Rodrigues, Jessica; Antunes, Luís; Bento, Maria José; Lunet, Nuno. "Frequency of multiple primary cancers in North Portugal: a population-based study". Trabalho apresentado em 44th Ascension Meeting, GRELL (Group for Cancer Epidemiology and Registration in Latin Language Countries), 2019.
  3. P. Nunes, Sandra; Moreira-Barbosa, Catarina; Salta, Sofia; Palma de Sousa, Susana; Pousa, Inês; Oliveira, Júlio; Soares, Marta; et al. "Early detection of the three major primary cancers in women by cell-free DNA methylation in liquid biopsies". Trabalho apresentado em 3rd ASPIC International Congress, 2018.
  4. Farinha, Nuno J.; Costa-Pinheiro, Pedro; Monteiro-Reis, Sara; Afonso, Mariana; Barroca, Helena; Antunes, Luís; Henrique, Rui; Jerónimo, Carmen. "Hypomethylation of GLIPR1 is a potential marker of blastema in Wilms' tumor". Trabalho apresentado em 46th Congress of the International Society of Paediatric Oncology (SIOP), 2014.
  5. Monteiro-Reis, Sara; Leça, Luís; Almeida, Mafalda; Antunes, Luís; Monteiro, Paula; Dias , Paula; Morais, António; et al. "The usefulness of a panel of three epigenetic biomarkers in detecting upper urinary tract urothelial cell carcinoma". Trabalho apresentado em Biologia na Parede - Faculdade de Ciências da Universidade do Porto, 2011.
Resumo em conferência
  1. Barbosa, Barbara; Bravo, I. ; Antunes, Luís; Dias, Anabela. "WP 7 -Digital Skills for Therapy Radiographers (TR) - A document analysis". Trabalho apresentado em SRM¿s International Conference on Medical Imaging and Radiotherapy, 2020.
    Publicado • doi.org/10.14614/RADINTCONFMALTA/2020/
  2. Morais, Samantha; Antunes, Luís; Bento, Maria José; Lunet, Nuno. "The effect of a gastric second primary cancer on the survival of patients with a previous cancer". Trabalho apresentado em XXXVII Reunión Anual de la Sociedad Española de Epidemiología/XIV Congresso da Associação Portuguesa de Epidemiologia/XVIII Congreso de la Sociedad Española de Sociedad Española de Salud Pública y Administración Sanitaria, Oviedo, 2019.
    Publicado
  3. Morais, Samantha; Antunes, Luís; Bento, Maria José; Lunet, Nuno. "Risk of a second primary gastric cancer following a first primary cancer". Trabalho apresentado em XXXVI Reunión Científica de la Sociedad Española de Epidemiología/XIII Congresso da Associação Portuguesa de Epidemiologia, Lisbon, 2018.
    Publicado
  4. Morais, Samantha; Antunes, Luís; Bento, Maria José; Lunet, Nuno. "Survival of gastric first primary cancer patients with a second primary cancer". Trabalho apresentado em XXXVI Reunión Científica de la Sociedad Española de Epidemiología/XIII Congresso da Associação Portuguesa de Epidemiologia, Lisbon, 2018.
    Publicado
  5. Morais, Samantha; Castro, C.; Antunes, Luís; Peleteiro, B; Bento, M.J.; Lunet, N. "Prediagnosis lifestyles, second primary cancer and survival in gastric cancer patients". Trabalho apresentado em XXXVI Reunión Científica de la Sociedad Española de Epidemiología/XIII Congresso da Associação Portuguesa de Epidemiologia, 2018.
    Publicado